During the past decade, Clinique des Ormeaux conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique des Ormeaux" #1 collaborator was "AIO-Studien-gGmbH" with 1 trials as a collaborator and "Grupo Español de Tratamiento de Tumores de Cabeza y Cuello" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clinique des Ormeaux" are "Head and Neck Squamous Cell Carcinoma" (1 trials) and "Squamous Cell Carcinoma of the Head and Neck" (1 trials). Many other conditions were trialed in "Clinique des Ormeaux" in a lesser frequency.

Most popular intervention types in "Clinique des Ormeaux" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracile" (1 trials), "Cetuximab" (1 trials), "Cisplatin" (1 trials), "Docetaxel" (1 trials) and "Durvalumab with Carboplatin/Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique des Ormeaux" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinique des Ormeaux". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinique des Ormeaux, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique des Ormeaux, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".